Han Zhuo
Key Laboratory Of Liver Transplantation, NHC Key Laboratory Of Living Donor Liver Transplantation
Nanjing, 210029, China
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Corrigendum to "RNF26 regulating tumor immunogenicity of hepatocellular carcinoma by degrading GRP78 and instigating ER stress" [Drug Resist. Updat. 86 (2026) 101375].
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: April 25, 2026
Beyond the single model: Critical considerations for translating HCC triplet immunotherapy from bench to bedside: Letter to the editor on "Distinct tumor immune microenvironment modulation by anti-PD-1/PD-L1, VEGF, and CTLA-4 blockade provides a rationale for triplet therapy in hepatocellular carcinoma".
Journal: Clinical and molecular hepatology
Published: December 10, 2025
RNF26 regulating tumor immunogenicity of hepatocellular carcinoma by degrading GRP78 and instigating ER stress.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: December 07, 2025
Somatic mutation correlation with lymph node metastasis and prognosis in T1/2 stage colorectal cancer patients: A propensity score matching analysis.
Journal: Clinical and translational medicine
Published: November 04, 2024
Gr-1 blockade remodels the immunosuppressive microenvironment induced by incomplete microwave ablation of hepatocellular carcinoma.
Journal: Cancer cell international
Published: November 09, 2023
Metformin Suppresses Hepatocellular Carcinoma through Regulating Alternative Splicing of LGR4.
Journal: Journal of oncology
Published: September 05, 2022
CircMYH9 increases KPNA2 mRNA stability to promote hepatocellular carcinoma progression in an EIF4A3-dependent manner.
Journal: American journal of cancer research
Published: June 16, 2022
CircASPH Promotes Hepatocellular Carcinoma Progression Through Methylation and Expression of HAO2.
Journal: Frontiers in oncology
Published: April 03, 2022
RP11-40C6.2 Inactivates Hippo Signaling by Attenuating YAP1 Ubiquitylation in Hepatitis B Virus-associated Hepatocellular Carcinoma.
Journal: Journal of clinical and translational hepatology
Published: December 26, 2021
Circulating circRNA predicting the occurrence of hepatocellular carcinoma in patients with HBV infection.
Journal: Journal of cellular and molecular medicine
Published: March 10, 2020
Last Updated: 09/26/2026